https://www.selleckchem.com/pr....oducts/nsc697923.htm
also been applied in the derivation of CMs in vitro to increase the efficiency and maturation of differentiation. Collectively, a lot has been learned from the past failure of simply injecting intact stem cells or their derivatives in vivo for treating MI, and bioengineering stem cells with biomaterials is expected to be a valuable strategy for advancing stem cell therapy towards its widespread application for treating MI in the clinic.Nonsynonymous single nucleotide polymorphisms (nsSNPs) are one of the most common forms of mutations
Like
Comment
Share
